| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 58,255 | 56,476 | 62,226 | | Cost of Revenue | 42,091 | 41,764 | 44,220 | | | Gross Profit | 16,164 | 14,712 | 18,006 | | | Operating Expenses | | Research Development | 11,878 | 10,707 | 8,856 | | Selling General and Administrative | 13,474 | 12,463 | 12,889 | | Non Recurring | 6,161 |
-
|
-
| | Others | 716 | 531 | 156 | | | | Total Operating Expenses | 32,229 |
-
|
-
| | | | Operating Income or Loss | (16,065) | (8,989) | (3,895) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,248 | 3,590 | 2,648 | | Earnings Before Interest And Taxes | (14,817) | (5,399) | (1,247) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (14,817) | (5,399) | (1,247) | | Income Tax Expense | (66) | 2 | 97 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (14,751) | (5,401) | (1,344) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (14,751) | (5,401) | (1,344) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($14,751) | ($5,401) | ($1,344) |
|
1.48% Nasdaq 
Income Statement
